STOCK TITAN

Serina Therapeutics, Inc. (SER) Debt by Year

SER

Serina Therapeutics, Inc. carried $2.9M in long-term debt against $3.1M in cash and equivalents at the end of fiscal year 2025. The change in long-term debt from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Serina Therapeutics, Inc. has filed alongside them.

FY2025 annual
Long-Term Debt $2.9M
Cash & Equivalents $3.1M
YoY n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SER Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Long-Term Debt$2.9Mn/m$0-100.0%$3.0M-83.5%$18.1M+37.3%$13.2MN/AN/AN/AN/A
Cash & Equivalents$3.1M-16.8%$3.7M-51.8%$7.6M+1081.2%$645K+10.4%$584K+10.8%$527K-77.6%$2.4M-64.9%$6.7M-9.1%$7.4M

SER Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Long-Term Debt$3.1M$3.0M$2.9Mn/mN/AN/AN/A$0-100.0%$11.2MN/AN/A$3.0M-83.5%N/A
Cash & Equivalents$23.0M+281.1%$24.5M+474.8%$3.1M-16.8%$8.6M+170.6%$6.0M-0.4%$4.3M-51.0%$3.7M-51.8%$3.2M+702.3%$6.1M+2223.4%$8.7M+3009.3%$7.6M+1081.2%$397K-14.8%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Serina Therapeutics, Inc. financials

Frequently Asked Questions

What was Serina Therapeutics, Inc.'s long-term debt in fiscal year 2025?

Serina Therapeutics, Inc. carried $2.9M in long-term debt against $3.1M in cash and equivalents at the end of fiscal year 2025.

How fast is Serina Therapeutics, Inc.'s long-term debt growing?

Serina Therapeutics, Inc. (SER) reported $0 in long-term debt in fiscal year 2024 and $2.9M in long-term debt in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

What was Serina Therapeutics, Inc.'s long-term debt in the most recent quarter?

Serina Therapeutics, Inc. (SER) reported $3.1M in long-term debt in Q2 2026.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Serina Therapeutics, Inc. (SER) reported on that line in every period on record.